KnowGovRepresentation. Influence. Action.
BillS 4109 · 119

Stem Cell Therapeutic and Research Reauthorization Act of 2026

Introduced
Mar 17, 2026
Cosponsors
3
Traction
0
Last Action
Jun 22, 2026

Bill Summary

Reauthorizes funding for stem cell research and therapy programs. Extends existing programs to continue supporting medical research and treatment development using stem cells.

Sponsored By

Jack Reed
Democrat · Rhode Island · Senate

Bill Journey

  1. Mar 17, 2026
  4. Jun 22, 2026You Are Here

    The full chamber debates the bill, may amend it, and votes on whether to pass it.

  5. TBD

    If passed by the first chamber, the other chamber considers, may amend, and votes on the bill.

  6. TBD

    If passed by both chambers, the bill goes to the President to sign into law or veto.

Why It Matters

This bill affects medical researchers, patients with diseases or injuries that could be treated with stem cell therapies, and families relying on these treatments, by providing continued funding for research and development of new therapies. It also impacts healthcare providers and organizations involved in stem cell research and treatment.

Impact Areas

Sample
Addresses Supply
Targets an underlying shortage driving costs.
Supports Families
Aimed at easing pressure on working households.
Long-term Impact
Effects compound across multiple budget cycles.
Expands Access
Lowers barriers for first-time participants.

Support & Opposition

Sponsor & cosponsor support by party
4backers
  • Democratic2
  • Republican2
Cross-party cosponsors2 · 67%

Documents

1

Full text opens on congress.gov, the official source.

Cosponsors (3)

Bill Details

Bill TypeSenate Bill · Federal
Primary TopicHealth
CommitteeSenate Committee (sample)Sample
IntroducedMar 17, 2026
Last UpdatedJun 22, 2026
Latest ActionPlaced on Senate Legislative Calendar under General Orders. Calendar No. 443.
Subjects
  • Health

Summary and impact analysis written by Judy (KnowGov's enrichment AI). Bill metadata, status, sponsor, and any floor votes from Prism. Sections marked “Sample” are placeholders not yet connected to live data.